We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$757M
2
BABA icon
Alibaba
BABA
+$544M
3
BKNG icon
Booking.com
BKNG
+$475M
4
XLNX
Xilinx Inc
XLNX
+$377M
5
CAT icon
Caterpillar
CAT
+$285M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAS
4326
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$244K ﹤0.01%
78,547
+60,873
+344% +$203K
HGV icon
4327
CALL
Hilton Grand Vacations
HGV
$3.53B
$243K ﹤0.01%
5,100
– –
PANL icon
4328
Pangaea Logistics
PANL
$541M
$243K ﹤0.01%
+48,106
New +$236K
PRI icon
4329
Primerica
PRI
$9.17B
$242K ﹤0.01%
1,574
-100
-6% -$14.9K
FOXA icon
4330
PUT
Fox Class A
FOXA
$28.9B
$241K ﹤0.01%
+6,000
New +$221K
POWL icon
4331
Powell Industries
POWL
$7.02B
$241K ﹤0.01%
+29,463
New +$265K
EFX icon
4332
Equifax
EFX
$22.8B
$240K ﹤0.01%
948
-116,792
-99% -$30.4M
PRGO icon
4333
Perrigo
PRGO
$1.96B
$239K ﹤0.01%
5,053
-261,640
-98% -$11.6M
ZYME icon
4334
Zymeworks
ZYME
$2.1B
$239K ﹤0.01%
8,247
-537
-6% -$17.9K
ROSS.WS
4335
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$239K ﹤0.01%
268,888
+224,444
+505% +$205K
AVGO icon
4336
Broadcom
AVGO
$1.72T
$238K ﹤0.01%
4,910
-1,200
-20% -$58.4K
YUMC icon
4337
Yum China
YUMC
$16.3B
$238K ﹤0.01%
4,097
-7,398
-64% -$455K
RAIN
4338
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$238K ﹤0.01%
15,923
-11,799
-43% -$201K
COHR icon
4339
PUT
Coherent
COHR
$56B
$237K ﹤0.01%
4,000
– –
RSI icon
4340
Rush Street Interactive
RSI
$3.05B
$236K ﹤0.01%
12,302
-38,944
-76% -$533K
IOVA icon
4341
Iovance Biotherapeutics
IOVA
$3.77B
$235K ﹤0.01%
9,514
-16,072
-63% -$379K
KIDS icon
4342
OrthoPediatrics
KIDS
$652M
$235K ﹤0.01%
+3,589
New +$233K
LBTYA icon
4343
Liberty Global Class A
LBTYA
$3.66B
$235K ﹤0.01%
7,886
-9,195
-54% -$255K
BFX
4344
PUT
DELISTED
BowFlex Inc.
BFX
$233K ﹤0.01%
+25,000
New +$321K
BOKF icon
4345
BOK Financial
BOKF
$8.53B
$232K ﹤0.01%
2,590
-15,809
-86% -$1.35M
CLW icon
4346
Clearwater Paper
CLW
$343M
$232K ﹤0.01%
6,057
-28,581
-83% -$909K
AGYS icon
4347
Agilysys
AGYS
$3.17B
$231K ﹤0.01%
4,414
-871
-16% -$47.6K
BLSA
4348
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$231K ﹤0.01%
+23,127
New +$233K
CKPT
4349
DELISTED
Checkpoint Therapeutics
CKPT
$230K ﹤0.01%
6,963
-2,112
-23% -$62.4K
GNPX icon
4350
Genprex
GNPX
$3.31M
$230K ﹤0.01%
2
+1
+100% +$129K
172 173
174
175 176

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.